Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-25-082305
Filing Date
2025-06-05
Accepted
2025-06-05 16:05:17
Documents
4
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 6-K 6-k_agm_results_2025.htm 6-K 31555
2 EX-99.1 ocs-ex99_1.htm EX-99.1 18999
3 EX-99.2 ocs-ex99_2.htm EX-99.2 577186
4 GRAPHIC img187686630_0.jpg GRAPHIC 27915
  Complete submission text file 0000950170-25-082305.txt   667327
Mailing Address BAHNHOFSTRASSE 7 ZUG V8 6300
Business Address BAHNHOFSTRASSE 7 ZUG V8 6300 617-937-2423
Oculis Holding AG (Filer) CIK: 0001953530 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41636 | Film No.: 251027082
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)